Arthur Tzianabos - Jan 9, 2023 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role
Director
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Arthur O. Tzianabos
Stock symbol
FIXX
Transactions as of
Jan 9, 2023
Transactions value $
-$14,762
Form type
4
Date filed
1/11/2023, 03:05 PM
Previous filing
Jan 4, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Sale -$14.8K -10.6K -8.92% $1.39 108K Jan 9, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
F2 The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.38 to $1.41. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.